Amphastar Pharmaceuticals, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $65.6M | $72.4M | $66.1M | $67.8M | $53.6M | $50.2M | $53.7M |
| Accounts Receivable | $36.0M | $26.8M | $33.2M | $22.9M | $24.6M | — | — |
| Inventory | $63.6M | $79.8M | $70.7M | $82.3M | $69.9M | — | — |
| Total Current Assets | $187.8M | $184.1M | $175.9M | $198.0M | $173.0M | — | — |
| Property, Plant & Equipment | $180.5M | $152.9M | $142.2M | $138.3M | $116.6M | — | — |
| Goodwill | $4.5M | $4.0M | $3.7M | $4.5M | $280.0K | $280.0K | — |
| Intangible Assets (Excl. Goodwill) | $11.5M | $17.1M | $7.0M | $8.9M | $10.7M | — | — |
| Total Assets | $451.1M | $427.7M | $390.1M | $389.4M | $338.7M | — | — |
| Liabilities | |||||||
| Accounts Payable | $16.6M | $19.9M | $13.9M | $10.2M | $20.4M | — | — |
| Total Current Liabilities | $67.2M | $60.6M | $60.0M | $62.6M | $65.4M | — | — |
| Long-Term Debt | $45.7M | $36.0M | $40.3M | $42.7M | — | — | — |
| Total Liabilities | $117.3M | $98.5M | $94.6M | $107.5M | $87.2M | — | — |
| Stockholders' Equity | |||||||
| Retained Earnings | $72.6M | $70.9M | $60.3M | $63.1M | $73.8M | — | — |
| Total Stockholders' Equity | $333.7M | $329.3M | $295.5M | $281.9M | $251.5M | $233.4M | $208.5M |